nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics
|
Hieble, J.Paul |
|
2000 |
|
2-3 |
p. 163-171 9 p. |
artikel |
2 |
α1-Adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety
|
Melchiorre, C |
|
2000 |
|
2-3 |
p. 181-190 10 p. |
artikel |
3 |
Apoptosis induced by death receptors
|
Schneider, Pascal |
|
2000 |
|
2-3 |
p. 281-286 6 p. |
artikel |
4 |
Central nicotinic receptor ligands and pharmacophores
|
Glennon, Richard A |
|
2000 |
|
2-3 |
p. 103-114 12 p. |
artikel |
5 |
Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines
|
Sozzani, Silvano |
|
2000 |
|
2-3 |
p. 305-312 8 p. |
artikel |
6 |
Cholinergic receptors and neurodegenerative diseases
|
Gualtieri, Fulvio |
|
2000 |
|
2-3 |
p. 85-89 5 p. |
artikel |
7 |
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology
|
Tecle, H |
|
2000 |
|
2-3 |
p. 141-148 8 p. |
artikel |
8 |
Constitutive activity of G protein coupled receptors and drug action
|
Leurs, Rob |
|
2000 |
|
2-3 |
p. 327-331 5 p. |
artikel |
9 |
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors
|
Messer Jr., William S. |
|
2000 |
|
2-3 |
p. 135-140 6 p. |
artikel |
10 |
Editorial
|
|
|
2000 |
|
2-3 |
p. v- 1 p. |
artikel |
11 |
Enigmatic receptors
|
Brasili, Livio |
|
2000 |
|
2-3 |
p. 201-203 3 p. |
artikel |
12 |
Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications
|
Trist, D.G |
|
2000 |
|
2-3 |
p. 221-229 9 p. |
artikel |
13 |
Excitatory amino acid receptors
|
Gaviraghi, G |
|
2000 |
|
2-3 |
p. 219-220 2 p. |
artikel |
14 |
General topics and perspectives
|
Timmerman, H |
|
2000 |
|
2-3 |
p. 313-314 2 p. |
artikel |
15 |
Hijacked receptors
|
Triggle, David J |
|
2000 |
|
2-3 |
p. 287-290 4 p. |
artikel |
16 |
ICAM-1 receptors and cold viruses
|
Bella, Jordi |
|
2000 |
|
2-3 |
p. 291-297 7 p. |
artikel |
17 |
Imidazoline receptors: a challenge
|
Bousquet, Pascal |
|
2000 |
|
2-3 |
p. 205-209 5 p. |
artikel |
18 |
Index
|
|
|
2000 |
|
2-3 |
p. 345-346 2 p. |
artikel |
19 |
Index
|
|
|
2000 |
|
2-3 |
p. 347-349 3 p. |
artikel |
20 |
Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse
|
Neumeyer, John L. |
|
2000 |
|
2-3 |
p. 337-344 8 p. |
artikel |
21 |
Ligands for the common allosteric site of acetylcholine M2-receptors: development and application
|
Holzgrabe, U |
|
2000 |
|
2-3 |
p. 149-155 7 p. |
artikel |
22 |
Metabotropic glutamate receptors: a structural view point
|
Pellicciari, Roberto |
|
2000 |
|
2-3 |
p. 231-237 7 p. |
artikel |
23 |
Neurotrophin receptor structure and interactions
|
Yano, Hiroko |
|
2000 |
|
2-3 |
p. 253-260 8 p. |
artikel |
24 |
New dimensions in G protein signalling: Gβ5 and the RGS proteins
|
Simonds, William F |
|
2000 |
|
2-3 |
p. 333-336 4 p. |
artikel |
25 |
Nicotinic systems in central nervous systems disease: degenerative disorders and beyond
|
Newhouse, Paul A |
|
2000 |
|
2-3 |
p. 91-101 11 p. |
artikel |
26 |
Pharmacological evidence of muscarinic receptor heterodimerization
|
Chiacchio, S |
|
2000 |
|
2-3 |
p. 315-326 12 p. |
artikel |
27 |
Pharmacological receptors: a century of discovery — and more
|
Triggle, David J |
|
2000 |
|
2-3 |
p. 79-84 6 p. |
artikel |
28 |
Receptors in cardiovascular disease: review and introduction
|
Leonardi, Amedeo |
|
2000 |
|
2-3 |
p. 157-161 5 p. |
artikel |
29 |
Receptors in neurodegenerative diseases
|
Froestl, Wolfgang |
|
2000 |
|
2-3 |
p. 247-251 5 p. |
artikel |
30 |
Receptors in neurodegenerative diseases, muscarinic cholinergic receptors
|
Angeli, Piero |
|
2000 |
|
2-3 |
p. 131-134 4 p. |
artikel |
31 |
Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist
|
Cosford, Nicholas D.P |
|
2000 |
|
2-3 |
p. 125-130 6 p. |
artikel |
32 |
Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke
|
Doré, Sylvain |
|
2000 |
|
2-3 |
p. 273-280 8 p. |
artikel |
33 |
Selection, design and evaluation of new radioligands for PET studies of cardiac adrenoceptors
|
Pike, V.W |
|
2000 |
|
2-3 |
p. 191-200 10 p. |
artikel |
34 |
Sigma receptors: recent advances and new clinical potentials
|
Bowen, Wayne D |
|
2000 |
|
2-3 |
p. 211-218 8 p. |
artikel |
35 |
Structural aspects of high affinity ligands for the α4β2 neuronal nicotinic receptor
|
Dart, Michael J. |
|
2000 |
|
2-3 |
p. 115-123 9 p. |
artikel |
36 |
Synthesis and pharmacological properties of novel glycine antagonists
|
Donati, D |
|
2000 |
|
2-3 |
p. 239-245 7 p. |
artikel |
37 |
The α1a and α1b-adrenergic receptor subtypes: molecular mechanisms of receptor activation and of drug action
|
Cotecchia, Susanna |
|
2000 |
|
2-3 |
p. 173-179 7 p. |
artikel |
38 |
The ciliary neurotrophic factor and its receptor, CNTFRα
|
Sleeman, Mark W |
|
2000 |
|
2-3 |
p. 265-272 8 p. |
artikel |
39 |
The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease
|
Mason, Ivor |
|
2000 |
|
2-3 |
p. 261-264 4 p. |
artikel |
40 |
Viral-encoded G-protein coupled receptors: new targets for drug research?
|
Smit, Martine J |
|
2000 |
|
2-3 |
p. 299-304 6 p. |
artikel |